Agilon Health (AGL) Reports Q2 Loss, Misses Revenue Estimates
Agilon Health (AGL) came out with a quarterly loss of $0.07 per share in line with the Zacks Consensus Estimate. This compares to loss of $0.04 per share a year ago.
IMPORTANT INVESTOR ALERT: The Schall Law Firm Encourages Investors in agilon health, inc. with Losses of $100,000 to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / May 19, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against agilon health, inc. ("agilon" or "the Company") (NYSE:AGL) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
IMPORTANT SHAREHOLDER ALERT: The Schall Law Firm Encourages Investors in agilon health, inc. with Losses of $100,000 to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / May 18, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against agilon health, inc. ("agilon" or "the Company") (NYSE:AGL) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
DEADLINE ACTION NOTICE: The Schall Law Firm Encourages Investors in agilon health, inc. with Losses of $100,000 to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / May 17, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against agilon health, inc. ("agilon" or "the Company") (NYSE:AGL) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of May 20, 2024 in agilon health Lawsuit - AGL
NEW YORK, NY / ACCESSWIRE / May 17, 2024 / If you suffered a loss on your agilon health, inc. (NYSE:AGL) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E.
IMPORTANT INVESTOR ALERT: The Schall Law Firm Encourages Investors in agilon health, inc. with Losses of $100,000 to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / May 16, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against agilon health, inc. ("agilon" or "the Company") (NYSE:AGL) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
